Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2494834

CN(C)C(=O)[C@@H]1C[C@H](O)CN1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.37
DPP8 Q6V1X1 4/20 0.34
DPP9 Q86TI2 4/20 0.34
GLI1 P08151 1/20 0.33
CHEK1 O14757 1/20 0.32
CHEK2 O96017 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALOX15 P16050 1/20 0.31
CYP2C19 P33261 1/20 0.31
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
CTSC P53634 1/20 0.30
SMYD3 Q9H7B4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2497613 1.00 DPP4 (0.37) DPP4DPP8DPP9GLI1CHEK1
Trifluoroacetic Acid SCHEMBL2496511 1.00 DPP4 (0.37) DPP4DPP8DPP9GLI1CHEK1
Trifluoroacetic Acid SCHEMBL2493610 1.00 DPP4 (0.37) DPP4DPP8DPP9GLI1CHEK1
SCHEMBL8259677 0.88 DPP4 (0.44) DPP4DPP8DPP9GLI1CHEK1
SCHEMBL3827353 0.88 DPP4 (0.44) DPP4DPP8DPP9GLI1CHEK1
SCHEMBL30537960 0.88 DPP4 (0.44) DPP4DPP8DPP9GLI1CHEK1
SCHEMBL6581948 0.88 DPP4 (0.44) DPP4DPP8DPP9GLI1CHEK1
SCHEMBL5471209 0.88 DPP4 (0.44) DPP4DPP8DPP9GLI1CHEK1
Hydrochloric Acid SCHEMBL1465100 0.86 DPP4 (0.42) DPP4DPP8DPP9GLI1CHEK1
Hydrochloric Acid SCHEMBL4208729 0.86 DPP4 (0.42) DPP4DPP8DPP9GLI1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 DPP4 2704/4885DPP8 2961/4885DPP9 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.